Related references
Note: Only part of the references are listed.Risk Prediction of Fever in Neutropenia in Children With Cancer: A Step Towards Individually Tailored Supportive Therapy?
Silvia Wicki et al.
PEDIATRIC BLOOD & CANCER (2008)
Current approaches for risk stratification of infectious complications in pediatric oncology
Christoph Haertel et al.
PEDIATRIC BLOOD & CANCER (2007)
Early hospital discharge versus continued hospitalization in febrile pediatric cancer patients with prolonged neutropenia: A randomized, prospective study
Nabil Ahmed et al.
PEDIATRIC BLOOD & CANCER (2007)
Admission clinical and laboratory factors associated with death in children with cancer during a febrile neutropenic episode
Maria E. Santolaya et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2007)
A prospective, multicentric scoring system to predict mortality in febrile neutropenic children with cancer
Hugo R. Paganini et al.
CANCER (2007)
New guidelines for the clinical management of febrile neutropenia and sepsis in pediatric oncology patients
Ana Verena Almeida Mendes et al.
JORNAL DE PEDIATRIA (2007)
Medical and non-medical barriers to outpatient treatment of fever and neutropenia in children with cancer
Gerardo Quezada et al.
PEDIATRIC BLOOD & CANCER (2007)
Cefepime monotherapy for treatment of febrile neutropenia in children
Hany Ariffin et al.
JOURNAL OF PAEDIATRICS AND CHILD HEALTH (2006)
Experience with cefepime versus meropenem as empiric monotherapy for neutropenia and fever in pediatric patients with solid tumors
A Oguz et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2006)
Monotherapy with piperacillin/tazobactam versus cefepime as empirical therapy for febrile neutropenia in pediatric cancer patients: A randomized comparison
F Corapcioglu et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2006)
Empirical antibiotic monotherapy for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials
M Paul et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Length of stay and mortality associated with febrile neutropenia among children with cancer
SK Basu et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Meropenem in the treatment of febrile neutropenic children
J Müller et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2005)
Cefepime vs. meropenem as empirical therapy for neutropenic fever in children with lymphoma and solid tumours
T Kutluk et al.
PEDIATRIC BLOOD & CANCER (2004)
Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children
S Aksoylar et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2004)
Early hospital discharge followed by outpatient management versus continued hospitalization of children with cancer, fever, and neutropenia at low risk for invasive bacterial infection
ME Santolaya et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Predicting bacteremia in children with fever and chemotherapy-induced neutropenia
RA Ammann et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2004)
Piperacillin-tazobactam and netilmicin as a safe and efficacious empirical treatment of febrile neutropenic children
N Le Guyader et al.
SUPPORTIVE CARE IN CANCER (2004)
Antimicrobial therapy of unexplained fever in neutropenic patients -: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society)
H Link et al.
ANNALS OF HEMATOLOGY (2003)
Prospective evaluation of a model of prediction of invasive bacterial infection risk among children with cancer, fever, and neutropenia
ME Santolaya et al.
CLINICAL INFECTIOUS DISEASES (2002)
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer
WT Hughes et al.
CLINICAL INFECTIOUS DISEASES (2002)
Randomized comparison of cefepime versus ceftazidime monotherapy for fever and neutropenia in children with solid tumors
R Kebudi et al.
MEDICAL AND PEDIATRIC ONCOLOGY (2001)
Risk factors assessment in fabrile neutropenia
M Paesmans
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2000)
Vancomycin use in pediatric hematology-oncology patients
HA Hopkins et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2000)
Share Paper
